Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111,247
datasets available to search
ShareScore release 0.9.0
Dataset results
111,247 results for “cells”
A Study Aimed to Assess the Needs of Subjects With Sickle Cell Disease and Healthcare Professionals Managing Sickle Cell Disease Patients in Selected Nigerian Centres
ClinicalTrials.gov study NCT04505969. IPD Sharing: YES. Countries: 1. Publications: 7.
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03088540. IPD Sharing: YES. Countries: 24. Publications: 4.
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02323126. IPD Sharing: YES. Countries: 8. Publications: 1.
Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients
ClinicalTrials.gov study NCT02268526. IPD Sharing: YES. Countries: 6. Publications: 1.
A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
ClinicalTrials.gov study NCT01896102. IPD Sharing: YES. Countries: 6. Publications: 3.
Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04436107. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03410108. IPD Sharing: YES. Countries: 1. Publications: 2.
A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
ClinicalTrials.gov study NCT03765788. IPD Sharing: YES. Countries: 1. Publications: 2.
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
ClinicalTrials.gov study NCT02633800. IPD Sharing: YES. Countries: 7. Publications: 2.
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03570892. IPD Sharing: YES. Countries: 18. Publications: 3.
Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
ClinicalTrials.gov study NCT02371369. IPD Sharing: YES. Countries: 12. Publications: 5.
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04619004. IPD Sharing: YES. Countries: 16. Publications: 2.
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04644237. IPD Sharing: YES. Countries: 10. Publications: 2.
Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
ClinicalTrials.gov study NCT04053764. IPD Sharing: YES. Countries: 11. Publications: 2.
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
ClinicalTrials.gov study NCT03906227. IPD Sharing: YES. Countries: 1. Publications: 1.
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04205812. IPD Sharing: YES. Countries: 17. Publications: 1.
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
ClinicalTrials.gov study NCT03264989. IPD Sharing: YES. Countries: 1. Publications: 3.
Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
ClinicalTrials.gov study NCT03657160. IPD Sharing: YES. Countries: 27. Publications: 1.
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03774082. IPD Sharing: YES. Countries: 14. Publications: 1.
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01828099. IPD Sharing: YES. Countries: 29. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.